ASTION PHARMA A/S: Financial statements 2024
CVR: 34224781
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -115,576 and a net result of DKK -246,248 compared with DKK 10,935 the year before. Equity in the 2024 report amounted to DKK -5,785,693.
- Gross Profit
- DKK -115,576
- Profit/Loss
- DKK -246,248
- Equity
- DKK -5,785,693
- Total Assets
- DKK 2,985,544
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -116K | -246K | -5.8M | - |
| 2023 | - | 132K | 11K | -5.5M | - |
| 2022 | - | 206K | 25K | -5.6M | - |
| 2021 | - | -1.4M | -6.3M | -5.6M | - |
| 2020 | - | -3.6M | -4.8M | 697K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ASTION PHARMA A/S has published its annual report for 2023. Gross profit came to DKK 132,462, and the net result was DKK 10,935.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.